Oral Anticoagulation
1Department of Cardiology, Angiology and Intensive Care Medicine (Department of Internal Medicine I), University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
Background:
Much new evidence on oral anticoagulation has come to light in recent years. Non-vitamin-K-dependent oral anti- coagulants (NOAC) have been developed and have been introduced into clinical practice. In this review, we present the current state of the evidence on anticoagulation for various indications with vitamin K antagonists (VKA) and with NOAC.
Methods:
This review is based on pertinent articles retrieved by a selective search in PubMed (search terms: anticoagulation, atrial fibrillation, prosthetic valve, thrombosis, pulmonary embolism) and on specialty society recommendations and relevant guidelines from the years 2000-2018.
Results:
The main indications for oral anticoagulation are atrial fibrillation, venous thromboembolism, and status post heart valve replacement. In patients with atrial fibrillation and without valvular heart disease, anticoagulation is recommended for men with a CHA2DS2-VASc score ≥ 1 and for women with a score ≥ 2. NOAC for this indication are associated with a marginally lower rate of stroke than VKA (3.5% vs. 3.8%, number needed to treat [NNT] = 333) as well as a lower rate of major hemorrhage (5.1% vs. 6.2%, NNT = 91). NOAC are contraindicated for patients with mechanical heart valves. Anticoagulation with VKA can be predictably antagonized. Among the various types of NOAC, the anticoagulant effect of dabigatran can be safely antagonized with an antidote; no specific antidote is yet available for apixaban, rivaroxaban, or edoxaban.
Conclusion:
The evidence base for anticoagulation over a time frame of several years is inadequate at present, and direct comparative data for the different types of NOAC are not yet available.
Insights
Newer non-vitamin-K-dependent oral anticoagulants (NOAC) show similar efficacy and safety to vitamin K antagonists (VKA) for stroke prevention, but evidence remains limited for long-term use.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Recent advancements have introduced non-vitamin-K-dependent oral anticoagulants (NOAC) alongside traditional vitamin K antagonists (VKA).
- This review synthesizes current evidence on oral anticoagulation therapies for diverse clinical indications.
Purpose of the Study:
- To review and compare the evidence for vitamin K antagonists (VKA) and non-vitamin-K-dependent oral anticoagulants (NOAC) in various anticoagulation indications.
- To highlight current guidelines and clinical practice regarding oral anticoagulation.
Main Methods:
- A selective PubMed search was conducted for articles published between 2000 and 2018.
- Key search terms included anticoagulation, atrial fibrillation, prosthetic valve, thrombosis, and pulmonary embolism.
- Specialty society recommendations and relevant clinical guidelines were also incorporated.
Main Results:
- Oral anticoagulation is primarily indicated for atrial fibrillation, venous thromboembolism, and post-heart valve replacement.
- For atrial fibrillation without valvular heart disease, NOACs demonstrated a marginally lower stroke rate (3.5% vs. 3.8%) and major hemorrhage rate (5.1% vs. 6.2%) compared to VKAs.
- NOACs are contraindicated in patients with mechanical heart valves, and while dabigatran has an antidote, others (apixaban, rivaroxaban, edoxaban) do not yet have specific antidotes.
Conclusions:
- The current evidence base for long-term oral anticoagulation is insufficient.
- Direct comparative data among different non-vitamin-K-dependent oral anticoagulants are not yet available.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Oral Cavity
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
Oral Hypoglycemic Agents: Glinides
Psychosexual Stages of Personality: Oral
Weaning, typically occurring...
Assessing Body Temperature - Oral
Step 1:
Start by practicing proper hand hygiene to prevent the spread of microorganisms.
Step 2:
Take the thermometer out of the charging unit, switch it on, and wait for the ready sign.
Step 3:
Gently slide the probe cover until a click is heard. This simple action prevents cross-contamination and ensures the correct placement of the probe cover.
Step 4:
Instruct the patient to open their mouth and place...


